BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22438253)

  • 1. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.
    Balabanian K; Brotin E; Biajoux V; Bouchet-Delbos L; Lainey E; Fenneteau O; Bonnet D; Fiette L; Emilie D; Bachelerie F
    Blood; 2012 Jun; 119(24):5722-30. PubMed ID: 22438253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
    Bachelerie F
    Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
    Dotta L; Tassone L; Badolato R
    Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
    Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
    Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.
    Balabanian K; Levoye A; Klemm L; Lagane B; Hermine O; Harriague J; Baleux F; Arenzana-Seisdedos F; Bachelerie F
    J Clin Invest; 2008 Mar; 118(3):1074-84. PubMed ID: 18274673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
    Balabanian K; Lagane B; Pablos JL; Laurent L; Planchenault T; Verola O; Lebbe C; Kerob D; Dupuy A; Hermine O; Nicolas JF; Latger-Cannard V; Bensoussan D; Bordigoni P; Baleux F; Le Deist F; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
    Blood; 2005 Mar; 105(6):2449-57. PubMed ID: 15536153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organs.
    Majumdar S; Pontejo SM; Jaiswal H; Gao JL; Salancy A; Stassenko E; Yamane H; McDermott DH; Balabanian K; Bachelerie F; Murphy PM
    J Immunol; 2023 Jun; 210(12):1913-1924. PubMed ID: 37133343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.
    Gulino AV; Moratto D; Sozzani S; Cavadini P; Otero K; Tassone L; Imberti L; Pirovano S; Notarangelo LD; Soresina R; Mazzolari E; Nelson DL; Notarangelo LD; Badolato R
    Blood; 2004 Jul; 104(2):444-52. PubMed ID: 15026312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
    Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
    Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses.
    Tarrant TK; Billard MJ; Timoshchenko RG; McGinnis MW; Serafin DS; Foreman O; Esserman DA; Chao NJ; Lento WE; Lee DM; Patel D; Siderovski DP
    J Leukoc Biol; 2013 Dec; 94(6):1243-51. PubMed ID: 23935208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization.
    Freitas C; Wittner M; Nguyen J; Rondeau V; Biajoux V; Aknin ML; Gaudin F; Beaussant-Cohen S; Bertrand Y; Bellanné-Chantelot C; Donadieu J; Bachelerie F; Espéli M; Dalloul A; Louache F; Balabanian K
    J Exp Med; 2017 Jul; 214(7):2023-2040. PubMed ID: 28550161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation.
    Gallego C; Vétillard M; Calmette J; Roriz M; Marin-Esteban V; Evrard M; Aknin ML; Pionnier N; Lefrançois M; Mercier-Nomé F; Bertrand Y; Suarez F; Donadieu J; Ng LG; Balabanian K; Bachelerie F; Schlecht-Louf G
    Blood; 2021 May; 137(20):2770-2784. PubMed ID: 33512478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.
    Maciejewski-Duval A; Meuris F; Bignon A; Aknin ML; Balabanian K; Faivre L; Pasquet M; Barlogis V; Fieschi C; Bellanné-Chantelot C; Donadieu J; Schlecht-Louf G; Marin-Esteban V; Bachelerie F
    J Leukoc Biol; 2016 Jun; 99(6):1065-76. PubMed ID: 26710799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization.
    Biajoux V; Natt J; Freitas C; Alouche N; Sacquin A; Hemon P; Gaudin F; Fazilleau N; Espéli M; Balabanian K
    Cell Rep; 2016 Sep; 17(1):193-205. PubMed ID: 27681431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
    de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
    J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive Immunodeficiency in WHIM Syndrome.
    Majumdar S; Murphy PM
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHIM syndrome: congenital immune deficiency disease.
    Kawai T; Malech HL
    Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.
    Majumdar S; Gao JL; Pontejo SM; Balabanian K; Bachelerie F; Murphy PM
    Immunohorizons; 2022 Jul; 6(7):543-558. PubMed ID: 35882421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.
    McDermott DH; Liu Q; Ulrick J; Kwatemaa N; Anaya-O'Brien S; Penzak SR; Filho JO; Priel DA; Kelly C; Garofalo M; Littel P; Marquesen MM; Hilligoss D; Decastro R; Fleisher TA; Kuhns DB; Malech HL; Murphy PM
    Blood; 2011 Nov; 118(18):4957-62. PubMed ID: 21890643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected developments in immune organs in WHIM syndrome.
    Murphy PM; McDermott DH
    Blood; 2012 Jun; 119(24):5610-2. PubMed ID: 22700690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.